Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors.
Author(s) -
Michio Terai,
Shinji Usuda,
Izumi KUROIWA,
Osamu Noshiro,
Hiroo Maeno
Publication year - 1983
Publication title -
the japanese journal of pharmacology
Language(s) - English
Resource type - Journals
eISSN - 1347-3506
pISSN - 0021-5198
DOI - 10.1254/jjp.33.749
Subject(s) - spiperone , dopaminergic , chemistry , dopamine receptor , endocrinology , sulpiride , 5 ht2 receptor , medicine , pharmacology , dopamine receptor d2 , receptor , chlorpromazine , dopamine , serotonin , 5 ht receptor
Effects of YM-09151-2 and five other neuroleptics (haloperidol, spiperone, chlorpromazine, sulpiride and clozapine) on the binding of [3H]-ligands to nine different receptors (alpha 1-adrenergic, alpha 2-adrenergic, beta-adrenergic, muscarinic, D2-dopaminergic, H1-histaminergic, 5HT1-serotonergic, 5HT2-serotonergic and opiate receptors) and on dopamine-sensitive adenylate cyclase were determined using brain membranes in the rat, guinea-pig and dog. The affinity of YM-09151-2 for D2-receptors with a Ki value of 0.1 nM was more than 1000-times higher than that for the other receptors and dopamine-sensitive adenylate cyclase, and it was the greatest among the neuroleptics tested.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom